Author | Lightnews

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 1d

The complexity of managing a patient with CTD-PAH can be dizzying. 😵‍💫
Our latest paper breaks down the management of these patients into practical pieces.

journals.sagepub.com/doi/10.1177/...

CTD-PAH: an updated practical approach to screening, diagnosis, and management - Noura Alturaif, Fatima K. Alduraibi, 2025

Connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) is a progressive and high-risk subtype of PAH, with outcomes generally worse than...

journals.sagepub.com

1 1

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 7d

Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT
@tarespirdis.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#NSCLC #radiomics #medicalimaging #precisiononcology #openaccess

1

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 25d

Lungs on fire 🔥 - the ERS session on respiratory infections is about to kick off. Looking forward to insights from Associate Editor Tom Wilkinson, who's joining as a discussant. #ERSCongress2025 #ERS2025 #RespiratoryHealth

1

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 25d

Later today Associate Editor Corrado Pelaia is chairing a session at #ERS2025: Remission/stability in airway diseases – how to achieve it and what’s next?
Exploring strategies for long-term disease control and emerging research.
#ERSCongress2025 #AirwayDiseases

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 25d

At #ERS2025, Associate Editor Dr Shaney Barratt chaired a poster session on Clinical prognostication in pulmonary fibrosis.
The session highlighted current approaches and future directions in predicting disease progression.
#ERSCongress2025 #PulmonaryFibrosis

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 25d

Great to connect with Editor-in-Chief Dr. Nazia Chaudhuri and several Associate Editors of Therapeutic Advances in Respiratory Disease at #ERSCongress2025 yesterday. Valuable discussions around editorial priorities and future plans!

#ERS2025 #RespiratoryDisease
@ild-ipfdoc.bsky.social

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 26d

🔥 Lungs on Fire: Interstitial Lung Diseases is now live at #ERS2025 - a packed session co-chaired by our Editor-in-Chief, Dr Nazia Chaudhuri.

#ERSCongress

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 26d

📣Just published: a plain language summary of publication exploring how doctors and patients communicate about treatment for systemic sclerosis-associated interstitial lung disease.

👉Read it here: journals.sagepub.com/doi/full/10....

#SSc #ILD

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 26d

It's our second day at #ERS2025! Today’s programme includes sessions chaired by our Associate Editors and Editor-in-Chief.

Looking forward to the discussions ahead. #ERSCongress

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27d

📢About to begin: ALERT 2 – Infections, Lung Cancer and Respiratory Symptoms Management

Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁
#ERSCongress2025

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27d

Enjoyed the session on Emerging Clinical Trials in Pulmonary Fibrosis, co-chaired by our Editor-in-Chief Dr. Nazia Chaudhuri.

A popular and timely discussion with lots of interest from attendees.

#ERS2025 #ERSCongress2025 #ClinicalTrials

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27d

Great turnout at ALERT 1: Obstructive Airway Diseases in Children and Adults, with our Associate Editor Prof Antonio Spanevello contributing as a discussant.

Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27d

📍#ERSCongress Check out this fascinating abstract: “Mepolizumab induces proteome changes in eosinophils from severe eosinophilic asthma” - coauthored by our editorial board member Francisco-Javier Gonzalez-Barcala.

#ERS2025 #Asthma

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27d

Excited to be at #ERSCongress today!
Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine

2

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · Sep 22

📍 Heading to Amsterdam for #ERSCongress this week!

Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch!

Follow along for updates from the congress! 🫁

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · Jun 20

The correlation between the level of therapy adherence and inhalation technique in children with uncontrolled asthma using a smart inhaler: the IMAGINE study
@tarespirdis.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#ehealth #pediatric #medicine #medsky #openaccess

1

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · Jun 20

Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
@tarespirdis.bsky.social @journals.sagepub.com

journals.sagepub.com/doi/10.1177/...
#ALS #neuromuscular #healthcare #openaccess

1

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · Jun 27

Therapeutic options for patients with pulmonary hypertension and interstitial lung disease
@tarespirdis.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#respiratorydisease #treatment #medicine #medsky #openaccess

3 6

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · Sep 12

Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine
@tarespirdis.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#artificialintelligence #genetictesting #medsky #lungdisease #openaccess

1 1

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · May 9

Immunosuppression is a core part of managing interstitial lung diseases. Learn how outcomes differ between antisynthetase syndrome and systemic sclerosis in response to treatment!

journals.sagepub.com/doi/full/10....

1 1

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · May 9

Don't lose the forest for the trees! Check out this forest plot in our latest meta-analysis on cardiovascular risk in patients with asthma!

journals.sagepub.com/doi/10.1177/...

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · Apr 22

🔥Hot off the press! Glucocorticoids are a cornerstone of therapy for many respiratory conditions. However, there are unintended effects. Here's a comprehensive review of the impact of cumulative glucocorticoid dosage in immunocompromised patients.

journals.sagepub.com/doi/10.1177/...

1 3

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · Apr 15

Severe asthma is a deadly disease ☠️
Read the latest review on inhaled triple therapy in patients with severe asthma!

journals.sagepub.com/doi/10.1177/...

1 1

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · Apr 7

April is Sarcoidosis Awareness Month. Throwback to our paper on the management of sarcoidosis.

journals.sagepub.com/doi/full/10....

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · Apr 7

From targeted therapy to multidisciplinary management, Cystic Fibrosis has outlined a standard model for research and management of complex respiratory diseases. Please check out our latest review!

journals.sagepub.com/doi/10.1177/...

1 1